Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
dihydrocodeintartrat 60 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
dihydrocodeintartrat 90 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
dihydrocodeintartrat 120 mg tablet med modificeret udløsning |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
dihydrocodeintartrat 40 mg tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Levacetylmethadol hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Product containing methadone analog (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Product containing opioid receptor agonist (product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Opioid-induced organic mental disorder |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Opioid-induced psychotic disorder with hallucinations |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
Opioid-induced psychotic disorder with delusions |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Opioid-induced mood disorder |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
Opioid intoxication delirium |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Harmful pattern of use of opioid (disorder) |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Product containing dihydrocodeine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
opiater |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Opioid-induced sexual dysfunction |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
Quantitative measurement of opiate agonist |
Component |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Opioid intoxication |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Opioid withdrawal |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Product containing dextromoramide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Foster eller nyfødt påvirket af placenta- eller brystoverførsel af narkotika |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Urine opiate measurement |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
[X]Poisoning by other opioids |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
[X]Poisoning by other synthetic narcotics |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
[X]Poisoning by other and unspecified narcotics |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Adverse reaction to other opiates and related narcotics |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Adverse reaction to opiates or related narcotics NOS |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Dextropropoxyphene napsylate 50 mg and paracetamol 325 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Dextropropoxyphene napsylate 100 mg and paracetamol 650 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Aspirin 389 mg and caffeine 32.4 mg and dextropropoxyphene hydrochloride 65 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Oral fluid opiate level (procedure) |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
Urine methadone metabolite level (procedure) |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
acetylsalicylsyre + caffein + propoxyphenhydrochlorid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
paracetamol + propoxyphennapsylat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
paracetamol + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Caffeine 30 mg and dihydrocodeine tartrate 16 mg and paracetamol 356.4 mg oral capsule |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Product containing precisely caffeine 60 milligram and dihydrocodeine tartrate 32 milligram and paracetamol 712.8 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Product containing precisely aspirin 356.4 milligram and caffeine 30 milligram and dihydrocodeine tartrate 16 milligram/1 each conventional release oral capsule (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
acetylsalicylsyre + caffein + dihydrocodeinbitartrat |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Propoxyphene |
Is a |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Phenazocine (substance) |
Is a |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Methadone analog (substance) |
Is a |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
|
[X]Opioids and related analgesics causing adverse effects in therapeutic use |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Opioid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Opioid dependence |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Opioid-induced sleep disorder |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Continuous opioid dependence |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Episodic opioid dependence |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Opioid dependence in remission |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
uspecificeret opioidafhængighed |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
opioidafhængighed, ikke nærmere specificeret |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
opioidafhængighed kombineret med anden afhængighed af psykoaktive stoffer eller lægemidler |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
opioidafhængighed kombineret med anden afhængighed af psykoaktive stoffer eller lægemidler, uspecificeret |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
opioidafhængighed kombineret med anden afhængighed af psykoaktive stoffer eller lægemidler, kontinuerlig |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
opioidafhængighed kombineret med anden afhængighed af psykoaktive stoffer eller lægemidler, episodisk |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
opioidafhængighed kombineret med anden afhængighed af psykoaktive stoffer eller lægemidler i remission |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
opioidafhængighed kombineret med anden afhængighed af psykoaktive stoffer eller lægemidler, ikke nærmere specificeret |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
[X]Mental and behavioral disorders due to use of opioids: dependence syndrome |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
forgiftning med narkotikum |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
accidentel forgiftning med narkotikum |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
tilsigtet forgiftning med narkotikum |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
forgiftning med narkotikum, uvist med hvilken hensigt |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Foster ELLER nyfødt påvirket af narkotikum overført via placenta OG/ELLER modermælk |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Nondependent harmful pattern of use of opioid |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Continuous nondependent harmful pattern of use of opioid (disorder) |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Episodic nondependent harmful pattern of use of opioid (disorder) |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Nondependent harmful pattern of use of opioid in remission (disorder) |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Nondependent opioid abuse, unspecified |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Nondependent opioid abuse NOS |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
[X]Poisoning by other synthetic narcotics |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
[X]Poisoning by other and unspecified narcotics |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Opiate or narcotic poisoning NOS |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Unspecified opium poisoning |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Forgiftning med opiat OG/ELLER beslægtet narkotikum |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Mersalyl measurement |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
måling af dihydrocodeinon |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Norfentanyl measurement |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Opioid screening |
Component |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Opiate misuse (finding) |
Associated with |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
måling af dihydromorphinon |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Narcotic withdrawal epilepsy |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
3 |
Moricizine measurement |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Paramethadione measurement |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Nalorphine measurement |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
måling af oxycodon |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Trimethadione measurement |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Dimethadione measurement |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
6-beta-Naltrexol measurement |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Accidental poisoning by opiate agonist |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Morphine (substance) |
Is a |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Pholcodine (substance) |
Is a |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Diamorphine (substance) |
Is a |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Tapentadol |
Is a |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
|
screeningsmåling af morfin |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Measurement of opiate agonist |
Component |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
1 |
Urine opiates screening test |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
Quantitative measurement of mass concentration of opiate agonist in serum or plasma specimen using gas chromatography mass spectrometry technique (procedure) |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
Measurement of norbuprenorphine in urine specimen (procedure) |
Component |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
Opioid dependence, on agonist therapy |
Causative agent |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |
Tramadol (substance) |
Is a |
True |
Opioid receptor agonist |
Inferred relationship |
Some |
|
Fetal or neonatal effect of narcotic transmitted via placenta |
Causative agent |
False |
Opioid receptor agonist |
Inferred relationship |
Some |
2 |